Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Day One Biopharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
NGM Biopharmaceuticals, Inc
Stanford University
Pfizer
ADC Therapeutics S.A.
Pfizer
Rutgers, The State University of New Jersey
Revolution Medicines, Inc.
Ludwig Institute for Cancer Research
Pfizer
Incyte Corporation
EMD Serono
National Institutes of Health Clinical Center (CC)
Beth Israel Deaconess Medical Center
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
Altor BioScience